申请人:Laboratoires Mayoly Spindler
公开号:US05811456A1
公开(公告)日:1998-09-22
Novel monoamine oxidase B inhibitors of formula (I), wherein R.sub.1 .dbd.H, an optionally substituted benzyloxy or phenylethoxy group; p=0-3; R.sub.3 .dbd.H, a CN, OH, CCH group, a C.sub.1 -C.sub.3 alkoxy-carbonyl group, or a C.sub.1 -C.sub.3 alkylated cyanomethyl group; R.sub.2 .dbd.H or a C.sub.1 -C.sub.3 alkyl group; n=0 or 1; if n=0, R.sub.4 is a C.sub.1 -C.sub.3 alkyl group or a C.sub.1 -C.sub.3 alkoxy group, while if n=1, y=1 and R.sub.4 is a C.sub.1 -C.sub.3 alkyl group, a C.sub.1 -C.sub.3 alkoxy group or a phenyl group. The invention also concerns processes for the preparation of said novel inhibitors and the therapeutic use thereof. ##STR1##
式(I)中的新型单胺氧化酶B抑制剂,其中R.sub.1=dbd.H,或是可选取代的苄氧基或苯乙氧基;p=0-3;R.sub.3=dbd.H,或是CN,OH,CCH基团,C.sub.1-C.sub.3烷氧基羰基基团,或是C.sub.1-C.sub.3烷基化的氰甲基基团;R.sub.2=dbd.H或是C.sub.1-C.sub.3烷基;n=0或1;如果n=0,R.sub.4是C.sub.1-C.sub.3烷基或C.sub.1-C.sub.3烷氧基群,而如果n=1,y=1且R.sub.4是C.sub.1-C.sub.3烷基,C.sub.1-C.sub.3烷氧基群或苯基。本发明还涉及制备所述新型抑制剂的方法以及其治疗用途。##STR1##